Zuyuan Shen

Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection

Qi Zhang, Qi Zhang, A. Satz, 2022, SLAS Discovery.

New small-molecule drug design strategies for fighting resistant influenza A

Weiqi Wang, Zuyuan Shen, Kaiyan Lou, 2015, Acta pharmaceutica Sinica. B.

Trideuteromethylation Enabled by a Sulfoxonium Metathesis Reaction.

Zuyuan Shen, Shilei Zhang, Xiaobei Chen, 2019, Organic letters.

Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro

Xuping Xie, P. Shi, V. Menachery, 2022, bioRxiv.

Practical Synthesis of C-1 Deuterated Aldehydes Enabled by NHC Catalysis

Zuyuan Shen, Wei Wang, Shilei Zhang, 2019, Nature Catalysis.

Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro

Vineet D. Menachery, Xuping Xie, P. Shi, 2023, ACS central science.

Control of the antitumour activity and specificity of CAR T cells via organic adapters covalently tethering the CAR to tumour cells

D. Bushnell, R. Kornberg, Jia Xie, 2023, Nature biomedical engineering.